Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Methotrexate (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 18 Dec 2015 New trial record